Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase γ (<em>POLG1</em>)

McFarland, R; Hudson, G; Taylor, RW; Green, SH; Hodges, S; McKiernan, PJ; Chinnery, PF; Ramesh, V

doi:10.1136/adc.2007.122911

Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase γ (POLG1)

Lookup NU author(s): Professor Bobby McFarland ORCiD, Professor Gavin Hudson ORCiD, Professor Robert Taylor ORCiD, Dr Stephen Hodges, Professor Patrick Chinnery, Dr Vankateswara Ramesh

Downloads

Published version [.pdf]

Abstract

We report the case of a 2-year-old boy with seizures who developed hepatic failure shortly after commencing sodium valproate. Unexpectedly, liver function returned to normal on stopping the drug. Sequencing of the mitochondrial polymerase γ gene (POLG1) revealed four heterozygous substitutions, two of which have been identified in cases of Alpers-Huttenlocher disease.

Publication metadata

Author(s): McFarland R, Hudson G, Taylor RW, Green SH, Hodges S, McKiernan PJ, Chinnery PF, Ramesh V

Publication type: Article

Publication status: Published

Journal: Archives of Disease in Childhood

Year: 2008

Volume: 93

Issue: 2

Pages: 151-153

Date deposited: 08/06/2010

ISSN (print): 0003-9888

ISSN (electronic): 1468-2044

Publisher: BMJ Group

URL: http://dx.doi.org/10.1136/adc.2007.122911

DOI: 10.1136/adc.2007.122911

PubMed id: 18208989

Altmetrics

Altmetrics provided by Altmetric

Funding

Funder reference	Funder name
G108/539	Medical Research Council